Blog Post March 26, 2021 2 MIN READ

Establishment Labs Statement Regarding TGA’s Regulatory Actions in Australia

Blog Post March 26, 2021 1 MIN READ

Establishment Labs Statement in Response to ANSM Decision to Ban Macrotextured and Polyurethane Breast Implants in France

Blog Post March 25, 2021 2 MIN READ

Establishment Labs was founded to improve safety and aesthetic outcomes in breast surgery.

Blog Post March 25, 2021 1 MIN READ

Establishment Labs Statement in Response to TGA’s Breast Implant Review related to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

404

No results were found

The page you requested could not be found. Use the button below or the navigation to get back on track.

Disclaimer

*This information is intended solely for the use of healthcare professionals. A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Motiva® does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it in a procedure or surgery. A healthcare professional must always refer to the package insert, product label and/or instructions for use before using any Motiva® product. The information presented is intended to demonstrate particular products, as well as the breadth of Motiva® product offerings. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your local representative if you have questions about the availability of specific products in your area. Motiva® products that are CE marked are marked according to the applicable EU Regulations and Directives.